Research Projects
Prospective, multicenter, open-label study to evaluate the efficacy of esmolol in the early identification of cardiovascular disorders induced by cirrhosis, diabetes mellitus and cardiotoxic treatments (bB-ECHO).
Researcher | Principal Investigator
Heart Failure Research Group
Research program
Cardiovascular Diseases
Research group
Heart Failure
Disease
Cardiovascular disease
Project information
To study the efficacy of esmolol in the early identification of cardiovascular alterations induced by cirrhosis, diabetes mellitus, and cardiotoxic treatments.
Esmolol is a drug used in routine medical practice for the treatment of cardiac arrhythmias or in serious situations where it is necessary to rapidly control arterial hypertension.
- Reference: bB-ECHO
- Start date: January 1, 2021
- End date: December 31, 2024
- Funder: Instituto de Salud Carlos III
- Nature of project: National
![icono-destacado-verde-contacto](/.imaging/dmsChain/dam/cima/imagenes/imagenes-iconos/icono-destacado-verde-contacto.jpg)
Need more information?
If you are interested in learning more about our research, please contact us.